Chikako Shimizu

6.4k total citations · 1 hit paper
180 papers, 3.7k citations indexed

About

Chikako Shimizu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Chikako Shimizu has authored 180 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Oncology, 45 papers in Pulmonary and Respiratory Medicine and 29 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Chikako Shimizu's work include HER2/EGFR in Cancer Research (39 papers), Cancer Treatment and Pharmacology (25 papers) and Ovarian cancer diagnosis and treatment (14 papers). Chikako Shimizu is often cited by papers focused on HER2/EGFR in Cancer Research (39 papers), Cancer Treatment and Pharmacology (25 papers) and Ovarian cancer diagnosis and treatment (14 papers). Chikako Shimizu collaborates with scholars based in Japan, United States and United Kingdom. Chikako Shimizu's co-authors include Yasuhiro Fujiwara, Kan Yonemori, Kenji Tamura, Masashi Ando, Mayu Yunokawa, Akihiko Shimomura, Noriyuki Katsumata, Takayuki Kinoshita, Makiko Ono and Tatsunori Shimoi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Chikako Shimizu

172 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody–drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study

2017 362 citations Akihiko Shimomura, Yasuhiro Fujiwara et al. profile →

Peers

Countries citing papers authored by Chikako Shimizu

Since Specialization

Citations

This map shows the geographic impact of Chikako Shimizu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chikako Shimizu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chikako Shimizu more than expected).

Fields of papers citing papers by Chikako Shimizu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chikako Shimizu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chikako Shimizu. The network helps show where Chikako Shimizu may publish in the future.

Co-authorship network of co-authors of Chikako Shimizu

This figure shows the co-authorship network connecting the top 25 collaborators of Chikako Shimizu. A scholar is included among the top collaborators of Chikako Shimizu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chikako Shimizu. Chikako Shimizu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	LBA12 5-year follow-up results from the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) trial 2025 ·Annals of Oncology ·(unknown), Samuel M. Niman, Marco Ruggeri, Fedro A. Peccatori, Hatem A. Azim, (unknown), C. Saura Manich, Chikako Shimizu, (unknown), (unknown), Erica T. Warner, Audrey Mailliez, Frédéric Amant, (unknown), Martine Piccart, Larissa A. Korde, Aron Goldhirsch, R.D. Gelber, AH Partridge	0
2	Case Report of Complete Response to Olaparib in a Patient with Breast Cancer Brain Metastases 2024 ·SHILAP Revista de lepidopterología ·(unknown), Akihiko Shimomura, (unknown), (unknown), Chikako Shimizu	1
3	1814O Breastfeeding in women with hormone receptor-positive breast cancer who conceived after temporary interruption of endocrine therapy: Results from the POSITIVE trial 2024 ·Annals of Oncology ·(unknown), Samuel M. Niman, AH Partridge, Marco Ruggeri, (unknown), C. Saura Manich, Chikako Shimizu, (unknown), Judith R. Kroep, (unknown), Frédéric Amant, Audrey Mailliez, Halle C. F. Moore, (unknown), Sarra El-Abed, R.D. Gelber, (unknown), Fedro A. Peccatori	3
4	Cancer incidence and type of treatment hospital among children, adolescents, and young adults in Japan, 2016–2018 2023 ·Cancer Science ·Kayo Nakata, Tomohiro Matsuda, Megumi Hori, Hiromi Sugiyama, (unknown), Isao Miyashiro, Kimikazu Matsumoto, Akihiro Yoneda, Junko Takita, Chikako Shimizu, Kota Katanoda	9
5	Diagnostic delays in breast cancer among young women: An emphasis on healthcare providers 2023 ·The Breast ·Luís Costa, Rakesh Kumar, Cynthia Villarreal‐Garza, (unknown), Sunil Saini, Jayanti Semwal, (unknown), (unknown), (unknown), (unknown), Chikako Shimizu, (unknown), Masakazu Toi, Allan Lipton	14
6	Cardiotoxicity of adjuvant chemotherapy with trastuzumab: a Japanese claim-based data analysis 2022 ·Open Heart ·Hiroshi Ohtsu, Akihiko Shimomura, Sakiko Miyazaki, Naohiro Yonemoto, Shinichiro Ueda, Chikako Shimizu, Kazuhiro Sase	4
7	Peripheral neuropathy from paclitaxel: risk prediction by serum microRNAs 2020 ·BMJ Supportive & Palliative Care ·(unknown), Akihiko Shimomura, Yuko Tanabe, (unknown), Juntaro Matsuzaki, Satoko Takizawa, Yoshiaki Aoki, Chikako Shimizu, Kenji Tamura, Takahiro Ochiya	8
8	Problems of reproductive function in survivors of childhood‐ and adolescent and young adult‐onset cancer revealed in a part of a national survey of Japan 2018 ·Reproductive Medicine and Biology ·Tatsuro Furui, Yasushi Takai, Fuminori Kimura, Michio Kitajima, Mikiya Nakatsuka, Ken‐ichiro Morishige, Akiko Higuchi, Chikako Shimizu, (unknown), Akira Ohara, Ryohei Tatara, Terukazu Nakamura, Keizo Horibe, Nao Suzuki	12
9	Efficacy of capecitabine in patients with locally advanced or metastatic breast cancer with or without prior treatment with fluoropyrimidine: a retrospective study 2018 ·Cancer Chemotherapy and Pharmacology ·(unknown), Akihiko Shimomura, Tatsunori Shimoi, Kazuki Sudo, Emi Noguchi, Kan Yonemori, Chikako Shimizu, Yasuhiro Fujiwara, Kenji Tamura	2
10	Fertility preservation in adolescent and young adult cancer patients: From a part of a national survey on oncofertility in Japan 2018 ·Reproductive Medicine and Biology ·Tatsuro Furui, Yasushi Takai, Fuminori Kimura, Michio Kitajima, Mikiya Nakatsuka, Ken‐ichiro Morishige, Akiko Higuchi, Chikako Shimizu, (unknown), Akira Ohara, Ryohei Tatara, Terukazu Nakamura, Keizo Horibe, Nao Suzuki	24
11	Current situation of cancer among adolescents and young adults in Japan 2018 ·International Journal of Clinical Oncology ·Akira Ohara, Tatsuro Furui, Chikako Shimizu, Seiichiro Ozono, Kazuhito Yamamoto, Akira Kawai, Ryohei Tatara, Akiko Higuchi, Keizo Horibe	17
12	Dose-dense paclitaxel plus carboplatin as neoadjuvant chemotherapy for advanced ovarian, fallopian tube, or primary peritoneal carcinomas 2016 ·Cancer Chemotherapy and Pharmacology ·Takahiro Ebata, Mayu Yunokawa, (unknown), Akihiko Shimomura, Tatsunori Shimoi, Makoto Kodaira, Kan Yonemori, Chikako Shimizu, Yasuhiro Fujiwara, Tomoyasu Kato, Kenji Tamura	11
13	Phase I and pharmacokinetic study of trastuzumab emtansine in Japanese patients with HER2-positive metastatic breast cancer 2014 ·Japanese Journal of Clinical Oncology ·Hiroshi Yamamoto, Masahiko Ando, K. Aogi, (unknown), Kenji Tamura, Kan Yonemori, Chikako Shimizu, Fumikata Hara, Daisuke Takabatake, Masaya Hattori, Tetsuya Asakawa, Yasuhiro Fujiwara	21
14	⁶⁴Cu-DOTA-Trastuzumab PET Imaging in Patients with HER2-Positive Breast Cancer 2013 ·Journal of Nuclear Medicine ·Kenji Tamura, Hiroaki Kurihara, Kan Yonemori, Hitoshi Tsuda, Junko Suzuki, Yuzuru Kono, Natsuki Honda, Makoto Kodaira, Harukaze Yamamoto, Mayu Yunokawa, Chikako Shimizu, Koki Hasegawa, Yousuke Kanayama, Satoshi Nozaki, Takayuki Kinoshita, Yasuhiro Wada, Shusaku Tazawa, Kazuhiro Takahashi, Yasuyoshi Watanabe, Yasuhiro Fujiwara	228
15	Physicians’ knowledge, attitude, and behavior regarding fertility issues for young breast cancer patients: a national survey for breast care specialists 2012 ·Breast Cancer ·Chikako Shimizu, Hiroko Bando, Tomoyasu Kato, (unknown), Seiichiro Yamamoto, Yasuhiro Fujiwara	69
16	Immunohistochemical expression of HER1, HER3, and HER4 in HER2‐positive breast cancer patients treated with trastuzumab‐containing neoadjuvant chemotherapy 2010 ·Journal of Surgical Oncology ·Kan Yonemori, Koji Tsuta, Chikako Shimizu, Yutaka Hatanaka, Akihiro Hirakawa, Makiko Ono, Tsutomu Kouno, Noriyuki Katsumata, Masashi Ando, Kenji Tamura, Tadashi Hasegawa, Takayuki Kinoshita, Yasuhiro Fujiwara	17
17	Second platinum therapy in patients with uterine cervical cancer previously treated with platinum chemotherapy 2010 ·Cancer Chemotherapy and Pharmacology ·Maki Tanioka, Noriyuki Katsumata, Kan Yonemori, Tsutomu Kouno, Chikako Shimizu, Kenji Tamura, Masashi Ando, Yasuhiro Fujiwara	14
18	Brain metastases in patients who receive trastuzumab-containing chemotherapy for HER2-overexpressing metastatic breast cancer 2009 ·International Journal of Clinical Oncology ·Makiko Ono, Masashi Ando, Mayu Yunokawa, Eriko Nakano, Kan Yonemori, Koji Matsumoto, Tsutomu Kouno, Chikako Shimizu, Kenji Tamura, Noriyuki Katsumata, Yasuhiro Fujiwara	30
19	Identification of Predictive Biomarkers for Response to Trastuzumab Using Plasma FUCA Activity and N-Glycan Identified by MALDI-TOF-MS 2009 ·Journal of Proteome Research ·Kunio Matsumoto, Chikako Shimizu, Tokuzo Arao, (unknown), Noriyuki Katsumata, (unknown), Kan Yonemori, Fumiaki Koizumi, Hideyuki Yokote, Kenjiro Aogi, Kenji Tamura, Kazuto Nishio, Yasuhiro Fujiwara	20
20	Long-term Outcome and Pattern of Relapse after Neoadjuvant Chemotherapy in Patients with Human Epidermal Growth Factor Receptor 2-positive Primary Breast Cancer 2009 ·Japanese Journal of Clinical Oncology ·Chikako Shimizu, (unknown), Kenichi Yoshimura, Hitoshi Tsuda, Maria Piera Mano, Masashi Ando, Kenji Tamura, Yasuhiro Fujiwara	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact